| 000 | 01842 a2200529 4500 | ||
|---|---|---|---|
| 005 | 20250513175724.0 | ||
| 264 | 0 | _c19990517 | |
| 008 | 199905s 0 0 eng d | ||
| 022 | _a0284-186X | ||
| 024 | 7 |
_a10.1080/028418699431690 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWarner, E | |
| 245 | 0 | 0 |
_aOutpatient 5-fluorouracil, folinic acid and cisplatin in patients with advanced esophageal carcinoma. _h[electronic resource] |
| 260 |
_bActa oncologica (Stockholm, Sweden) _c1999 |
||
| 300 |
_a255-9 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAdenocarcinoma _xdrug therapy |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
| 650 | 0 | 4 |
_aCarcinoma, Squamous Cell _xdrug therapy |
| 650 | 0 | 4 |
_aCisplatin _xadministration & dosage |
| 650 | 0 | 4 | _aDisease Progression |
| 650 | 0 | 4 | _aDrug Administration Schedule |
| 650 | 0 | 4 |
_aEsophageal Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFluorouracil _xadministration & dosage |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLeucovorin _xadministration & dosage |
| 650 | 0 | 4 |
_aLiver Neoplasms _xsecondary |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aOntario |
| 650 | 0 | 4 | _aSeverity of Illness Index |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aJensen, J L | |
| 700 | 1 | _aCripps, C | |
| 700 | 1 | _aKhoo, K E | |
| 700 | 1 | _aGoel, R | |
| 700 | 1 | _aKerr, I A | |
| 700 | 1 | _aBjarnason, G A | |
| 700 | 1 | _aFields, A L | |
| 700 | 1 | _aHrincu, A | |
| 773 | 0 |
_tActa oncologica (Stockholm, Sweden) _gvol. 38 _gno. 2 _gp. 255-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1080/028418699431690 _zAvailable from publisher's website |
| 999 |
_c10186569 _d10186569 |
||